Yunwei Han

625 total citations
28 papers, 453 citations indexed

About

Yunwei Han is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yunwei Han has authored 28 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yunwei Han's work include Extracellular vesicles in disease (7 papers), MicroRNA in disease regulation (6 papers) and Ferroptosis and cancer prognosis (5 papers). Yunwei Han is often cited by papers focused on Extracellular vesicles in disease (7 papers), MicroRNA in disease regulation (6 papers) and Ferroptosis and cancer prognosis (5 papers). Yunwei Han collaborates with scholars based in China, Canada and United States. Yunwei Han's co-authors include Jing Wang, Hongwei Zhang, Juan Fan, Hongwei Zhang, Hao Zeng, Shaozhi Fu, Yanling Zhang, Zhenhua Wu, Nan Shi and Hongju Mao and has published in prestigious journals such as Cancer, Free Radical Biology and Medicine and Biosensors and Bioelectronics.

In The Last Decade

Yunwei Han

27 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunwei Han China 13 293 166 116 86 63 28 453
Shuxian An China 14 266 0.9× 114 0.7× 149 1.3× 61 0.7× 51 0.8× 26 538
Ge Lou China 9 161 0.5× 108 0.7× 145 1.3× 66 0.8× 29 0.5× 23 384
Zhangru Yang China 12 240 0.8× 217 1.3× 149 1.3× 101 1.2× 39 0.6× 20 500
Bixiang Zhang China 13 360 1.2× 235 1.4× 63 0.5× 78 0.9× 58 0.9× 25 558
Kaili Liao China 11 255 0.9× 233 1.4× 126 1.1× 62 0.7× 64 1.0× 32 434
Lingxiong Wang China 14 296 1.0× 170 1.0× 188 1.6× 148 1.7× 151 2.4× 29 670
Dusica Cvetković United States 13 210 0.7× 91 0.5× 65 0.6× 114 1.3× 37 0.6× 34 446
Siwei Ju China 9 195 0.7× 154 0.9× 92 0.8× 79 0.9× 25 0.4× 17 355
Zhengqin Gu China 12 168 0.6× 101 0.6× 109 0.9× 66 0.8× 49 0.8× 27 367
Hui Ren China 8 229 0.8× 154 0.9× 164 1.4× 106 1.2× 70 1.1× 17 449

Countries citing papers authored by Yunwei Han

Since Specialization
Citations

This map shows the geographic impact of Yunwei Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunwei Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunwei Han more than expected).

Fields of papers citing papers by Yunwei Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunwei Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunwei Han. The network helps show where Yunwei Han may publish in the future.

Co-authorship network of co-authors of Yunwei Han

This figure shows the co-authorship network connecting the top 25 collaborators of Yunwei Han. A scholar is included among the top collaborators of Yunwei Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunwei Han. Yunwei Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Long, Gang, Qingwen Wang, Jihong Wang, et al.. (2025). ANG secretion predisposes endothelial cells toward angiogenesis in FIN56-induced ferroptotic hepatocellular carcinoma via the BMP6/ID1 signaling pathway. Free Radical Biology and Medicine. 238. 17–35. 1 indexed citations
3.
Wang, Huan, Chenghui Liu, Qiqi Xu, et al.. (2023). A polyoxometalate-based heterojunction nanozyme with peroxidase-mimic catalytic activity for sensitive biomolecule detection. Nanoscale Advances. 5(15). 3985–3993. 5 indexed citations
4.
Han, Yunwei, et al.. (2022). The overall process of metastasis: From initiation to a new tumor. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(4). 188750–188750. 26 indexed citations
5.
Chi, Hao, et al.. (2022). Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma. Journal of Oncology. 2022. 1–15. 25 indexed citations
6.
Wang, Juan, et al.. (2022). Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges. Frontiers in Oncology. 12. 884369–884369. 18 indexed citations
7.
Ye, Ling, Dawei Yang, Hongwei Zhang, et al.. (2021). Integrated microfluidic system for isolating exosome and analyzing protein marker PD-L1. Biosensors and Bioelectronics. 204. 113879–113879. 56 indexed citations
8.
Wang, Jing, Hao Zeng, Hongwei Zhang, & Yunwei Han. (2021). The role of exosomal PD-L1 in tumor immunotherapy. Translational Oncology. 14(5). 101047–101047. 43 indexed citations
9.
Yu, Fan, Yu Wang, Shaozhi Fu, et al.. (2021). CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis. Frontiers in Molecular Biosciences. 7. 616190–616190. 6 indexed citations
11.
Wang, Jing, Xinyue Huang, Jiali Xie, et al.. (2021). Exosomal analysis: Advances in biosensor technology. Clinica Chimica Acta. 518. 142–150. 33 indexed citations
12.
Li, Yinghua, et al.. (2020). Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study. Technology in Cancer Research & Treatment. 19. 1079231779–1079231779. 8 indexed citations
13.
Zeng, Qin, Yuan Li, Saber İmani, et al.. (2020). Bevacizumab combined with apatinib enhances antitumor and anti-angiogenesis effects in a lung cancer model in vitro and in vivo. Journal of drug targeting. 28(9). 961–969. 12 indexed citations
14.
Liu, Shanshan, Fei Wu, Yanling Zhang, et al.. (2020). Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model. Cancer Control. 27(1). 1148357817–1148357817. 11 indexed citations
15.
Li, Yuan, Pan Huang, Min Wu, et al.. (2019). <p>Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma</p>. Cancer Management and Research. Volume 11. 3469–3479. 13 indexed citations
16.
Xiong, Jian, Xiaoqiang Zhang, Yiping Wei, et al.. (2017). Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. Oncotarget. 8(8). 13157–13165. 20 indexed citations
17.
Yang, Bo, Xiaoyang Sun, Haowen Pang, et al.. (2017). Dosimetric analysis of rib interference of the CTV during interstitial brachytherapy of lung tumors. Journal of Contemporary Brachytherapy. 9(6). 566–571. 3 indexed citations
18.
Peng, Qiuxia, Yunwei Han, Yanling Zhang, et al.. (2017). Apatinib inhibits VEGFR-2 and angiogenesis in anin vivomurine model of nasopharyngeal carcinoma. Oncotarget. 8(32). 52813–52822. 47 indexed citations
19.
Deng, Xi, Jingbo Wu, Jianwen Zhang, et al.. (2016). MicroRNA-183 promotes migration and invasion of CD133+/CD326+ lung adenocarcinoma initiating cells via PTPN4 inhibition. Tumor Biology. 37(8). 11289–11297. 18 indexed citations
20.
Xie, Chao, et al.. (2015). Targeted inhibition of genome-wide DNA methylation analysis in epigenetically modulated phenotypes in lung cancer. Medical Oncology. 32(6). 615–615. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026